FAT1 mutations often disrupt cell adhesion and polarity, promoting oncogenic signaling, while CASP8 alterations can impair apoptotic responses or, conversely, drive pro-inflammatory and pro-survival pathways within the tumor microenvironment. This evidence concerns the gene CASP8 and neoplasm.